AK-778-XXMU, a powerful DNA Binding 2 (ID2) antagonist with a K D of 129 nM, exerts multifaceted effects by inhibiting cell migration and invasion of glioma cell lines, inducing apoptosis, and significantly retarding tumor growth [1].